Summary of teh Argument: The Flaws of the Value of Statistical Life (VSL)
This text critiques the use of the Value of Statistical Life (VSL) in cost-benefit analyses,notably within the context of EPA regulations. the author argues that VSL is a flawed metric as it both undervalues and overvalues life depending on the context, and fundamentally relies on an incomplete, individualistic outlook rather than a extensive social one.
Here’s a breakdown of the key points:
* VSL can undervalue life, especially for the elderly: Critics argue the EPA “values life at zero,” and the author suggests this isn’t far off for many elderly individuals, as thier healthcare savings and potential public care costs aren’t adequately considered.
* VSL can undervalue high-value lives: The example of Alex Honnold, the free climber, demonstrates this. His potential economic contribution and unique skills mean his life is worth far more than the VSL would suggest, based on the risk he took for a $500,000 payment.
* VSL focuses on risk, not outcomes: The author points out that “valuing risk” is only meaningful when a life is perhaps at stake. Policies should be judged on realized outcomes, not hypothetical lives saved.
* VSL is based on private, not social, value: The core issue is that VSL is derived from individual willingness to pay for risk reduction. This doesn’t account for:
* Externalities: Costs or benefits to others (e.g., healthcare costs, impact on future generations).
* Broader social trade-offs: The overall impact on society.
* VSL incorporates individual biases: People tend to discount the future, and this bias is imported into policy decisions when regulators simply accept individual preferences as given.
In essence,the author argues that VSL is a problematic tool for public policy because it fails to capture the full societal value of life and is susceptible to both underestimation and overestimation depending on the individual and the situation. They advocate for a more holistic approach that considers both the healthcare savings and the public costs associated with policies impacting lifespan.